This paper focuses on the practical use of cost-benefit analysis (or, more generally, of monetary valuation and other decision-making tools) in environmental policymaking. Based on a questionnaire sent to Environmental Ministries of OECD member countries, a review of the use of such analysis in...

The standard literature on the value of life relies on Yaari’s (1965) model, which includes an implicit assumption of risk neutrality with respect to life duration. To overpass this limitation, we extend the theory to a simple variety of preferences which are not necessarily additively...

Perfluorooctanoic acid (PFOA) is being used in fluoropolymer production, as surface treatment agents and for the manufacture of side-chain fluorinated polymers. However, there is evidence that PFOA and its salts have a number of hazardous properties that may cause harm to human health and the...

Dieser Beitrag entwickelt einen Vorschlag zur indikationsspezifischen Kosten-Nutzen-Bewertung. Zentrales Konzept ist ein sozialer Gesundheitsindex, der die Leistung des Gesundheitswesens misst. Er berücksichtigt nicht nur das Niveau der Gesundheit in der Bevölkerung, sondern auch deren...

We examine the net benefits of social distancing to slow the spread of COVID-19 in the United States. Social distancing saves lives but imposes large costs on society due to reduced economic activity. We use epidemiological and economic forecasting to perform a rapid benefit-cost analysis of...

Decisions on investing in health as well as other policies require deciding how to best allocate available resources - recognizing that using labor, materials, and other resources for one purpose means that they cannot be used for other purposes. Approaches for economic evaluation, including...

Federal health and safety regulations have saved or improved the lives of thousands of Americans, but protecting our citizens from risk entails significant costs. In a world of limited resources, we must spend our regulatory dollars responsibly in order to do the most we can with the money we...

Cost-effectiveness analysis is versatile and used widely to assist in health care decision making. This chapter discusses how cost-effectiveness analysis is used at the system or national level, particularly in the domain of coverage and payment policy. We describe its relationship to other...

The impact and economic merits of President Biden's Executive Order 13985 on equity depend on how the executive order is implemented. While policy discussion to date has focused on equitable outcomes, we propose framing risk equity policies in terms of equitable risk tradeoff rates based on six...

HIV continues to cause the largest number of disability-adjusted life years of any disease in HIV hyperendemic countries (i.e., countries with an adult HIV prevalence 15%). We compare the benefits and costs of two proven biological interventions to reduce the health losses due to the HIV...